Generic competition · all medicines · read 12 November 2026
Is there a generic of Abiraterone Acetate; Niraparib Tosylate, and who makes it?
Abiraterone Acetate; Niraparib Tosylate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.
Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made
- Abiraterone Acetate; Niraparib Tosylate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Brand listed, no generic listed as marketed
Brand listed as marketed: Akeega. No generic is listed as marketed.
Patents and exclusivities still listed
- 12 December 2028Exclusivity I-980 Akeega
- 12 August 2027Patent 8071579
- 12 August 2027Patent 8143241
- 24 April 2029Patent 8436185 drug substance
- 27 March 2031Patent 8071623 drug substance
- 4 August 2031Patent 8859562
- 28 July 2037Patent 11986468
- 28 July 2037Patent 11986469
- 28 July 2037Patent 11992486
6 more patents are listed.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
What do pharmacies pay for Abiraterone Acetate; Niraparib Tosylate?
The CMS NADAC survey tracks what pharmacies pay to acquire Abiraterone Acetate; Niraparib Tosylate: 2 products with year-end prices from 2020 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.